Charles Schwab’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Buy |
340,779
+30,472
| +10% | +$346K | ﹤0.01% | 2440 |
|
|
2025
Q1 | $2.06M | Sell |
310,307
-31,822
| -9% | -$212K | ﹤0.01% | 2609 |
|
|
2024
Q4 | $3.77M | Buy |
342,129
+25,995
| +8% | +$287K | ﹤0.01% | 2471 |
|
|
2024
Q3 | $3.89M | Buy |
316,134
+26,870
| +9% | +$330K | ﹤0.01% | 2492 |
|
|
2024
Q2 | $3.91M | Buy |
289,264
+66,226
| +30% | +$895K | ﹤0.01% | 2453 |
|
|
2024
Q1 | $3.01M | Buy |
223,038
+17,796
| +9% | +$240K | ﹤0.01% | 2475 |
|
|
2023
Q4 | $1.08M | Sell |
205,242
-12,097
| -6% | -$63.6K | ﹤0.01% | 2800 |
|
|
2023
Q3 | $856K | Buy |
217,339
+10,448
| +5% | +$41.2K | ﹤0.01% | 2847 |
|
|
2023
Q2 | $2.2M | Buy |
206,891
+43,176
| +26% | +$459K | ﹤0.01% | 2514 |
|
|
2023
Q1 | $1.36M | Sell |
163,715
-1,147
| -0.7% | -$9.56K | ﹤0.01% | 2631 |
|
|
2022
Q4 | $1.52M | Buy |
164,862
+2,617
| +2% | +$24.2K | ﹤0.01% | 2643 |
|
|
2022
Q3 | $2.08M | Sell |
162,245
-3,375
| -2% | -$43.4K | ﹤0.01% | 2574 |
|
|
2022
Q2 | $2.19M | Buy |
165,620
+14,888
| +10% | +$197K | ﹤0.01% | 2543 |
|
|
2022
Q1 | $3.17M | Buy |
150,732
+2,952
| +2% | +$62.1K | ﹤0.01% | 2484 |
|
|
2021
Q4 | $3.55M | Buy |
147,780
+1,783
| +1% | +$42.8K | ﹤0.01% | 2522 |
|
|
2021
Q3 | $3.72M | Buy |
145,997
+9,375
| +7% | +$239K | ﹤0.01% | 2508 |
|
|
2021
Q2 | $4.6M | Buy |
136,622
+14,262
| +12% | +$480K | ﹤0.01% | 2391 |
|
|
2021
Q1 | $4.75M | Buy |
122,360
+6,363
| +5% | +$247K | ﹤0.01% | 2327 |
|
|
2020
Q4 | $7.18M | Buy |
115,997
+22,238
| +24% | +$1.38M | ﹤0.01% | 2045 |
|
|
2020
Q3 | $3.14M | Buy |
93,759
+29,868
| +47% | +$1M | ﹤0.01% | 2307 |
|
|
2020
Q2 | $1.52M | Sell |
63,891
-6,512
| -9% | -$155K | ﹤0.01% | 2506 |
|
|
2020
Q1 | $1.61M | Buy |
70,403
+17,503
| +33% | +$401K | ﹤0.01% | 2350 |
|
|
2019
Q4 | $1.5M | Buy |
52,900
+546
| +1% | +$15.5K | ﹤0.01% | 2486 |
|
|
2019
Q3 | $1.13M | Buy |
+52,354
| New | +$1.13M | ﹤0.01% | 2533 |
|